FDA Commissioner Marty Makary Resigns Amid Vaping Policy Dispute
Summary
FDA Commissioner Marty Makary resigned amid reports of internal tensions and angering various groups, with Kyle Diamantas taking over as acting commissioner. Separately, the Trump administration plans to name ICE veteran David Venturella as the agency's interim director.
How coverage differs
Left outlets emphasize internal tensions leading to Makary's abrupt departure, while right outlets suggest he was fired due to his irrational resistance to flavored nicotine vapes.
- Left: Internal strife forces FDA Commissioner's resignation amidst policy clashes Left-leaning outlets report on FDA Commissioner Marty Makary's resignation, emphasizing 'internal tensions' within the agency as a key factor. They highlight the abrupt departure of a high-profile official from the Trump administration.
- Center: Agency in turmoil as Makary resigns, new acting commissioner named Center outlets report FDA Commissioner Marty Makary's resignation, noting that the agency is in 'turmoil' following his departure. They mention Kyle Diamantas has been named acting commissioner, succeeding Makary.
- Right: Commissioner's irrational vaping resistance led to his FDA resignation Right-leaning outlets focus on the contentious nature of Marty Makary's departure, with some suggesting he was effectively fired. They specifically highlight his 'irrational resistance' to flavored nicotine vapes as the driving force behind his resignation from the FDA.